{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:55:53Z","timestamp":1781171753234,"version":"3.54.1"},"reference-count":78,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>This review explores the potential of magistral formulas (MFs) as a viable option to meet the needs of neonates, given the lack of adequate therapies for this vulnerable group. The scientific literature on medicines available for neonates is limited. The physiological differences between neonates and adults make it difficult to formulate these medicines. In addition, there are a variety of difficulties in conducting research on neonates: few clinical trials are performed, and there is frequent use of unauthorized medicines. Pharmacokinetics in neonates was investigated in comparison to adults, and different aspects of the absorption, distribution, metabolism, and excretion were observed. One of the main problems is the different pharmacokinetics between the two populations. It is necessary to promote and allow research related to pediatric drug design, approve a specific authorization for use in age-appropriate dosage forms, and improve the quality and availability of information on drugs. This study focused on the MFs typically used for pediatrics, specifically for neonates, analyzing the pharmaceutical forms currently available and the presence of indications and dosage recommendations of the European Medicines Agency. Medications were classified according to therapeutic group, as antihypertensives, corticosteroids, and antiepileptics. The use of off-label medicines remains high in neonatal intensive care units and in primary healthcare, besides in the preparation of MFs by pharmacists. The shortage of medicines specifically designed and approved for neonates is a serious problem for society. Neonates continue to be treated, on numerous occasions, with off-label medicines. Studies and research should be expanded in this vulnerable population group.<\/jats:p>","DOI":"10.3390\/pharmaceutics17080963","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T12:56:43Z","timestamp":1753448203000},"page":"963","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalized Neonatal Therapy: Application of Magistral Formulas in Therapeutic Orphan Populations"],"prefix":"10.3390","volume":"17","author":[{"given":"Wenwen","family":"Shao","sequence":"first","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, 28922 Alcorc\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gomez","sequence":"additional","affiliation":[{"name":"\u00c1rea de Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Departamento de Ciencias B\u00e1sicas de la Salud, Universidad Rey Juan Carlos, 28922 Alcorc\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Alejano","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, 28922 Alcorc\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gil","sequence":"additional","affiliation":[{"name":"\u00c1rea de Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Departamento de Ciencias B\u00e1sicas de la Salud, Universidad Rey Juan Carlos, 28922 Alcorc\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Cristina","family":"Ben\u00e9itez","sequence":"additional","affiliation":[{"name":"\u00c1rea de Farmacia y Tecnolog\u00eda Farmac\u00e9utica, Departamento de Ciencias B\u00e1sicas de la Salud, Universidad Rey Juan Carlos, 28922 Alcorc\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"ref_1","unstructured":"(2025, May 23). E11(R1) Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population Guidance for Industry, Available online: https:\/\/www.fda.gov\/media\/101398\/download."},{"key":"ref_2","first-page":"301","article-title":"Patr\u00f3n cl\u00ednico-epidemiol\u00f3gico de la infecci\u00f3n en el reci\u00e9n nacido intervenido quir\u00fargicamente","volume":"85","year":"2013","journal-title":"Rev. Cuba. Pediatr\u00eda"},{"key":"ref_3","first-page":"57","article-title":"Sepsis neonatal","volume":"22","author":"Coronell","year":"2009","journal-title":"Rev. Enfermedades Infecc. Pediatr\u00eda"},{"key":"ref_4","first-page":"3","article-title":"Principales Patolog\u00edas De Ingreso En Uci Neonatal","volume":"V","year":"2022","journal-title":"Npunto"},{"key":"ref_5","unstructured":"(2025, May 23). Newborn Mortality. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/newborn-mortality."},{"key":"ref_6","unstructured":"(2025, May 23). Nacimientos Prematuros. Available online: https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/preterm-birth."},{"key":"ref_7","unstructured":"(2025, May 23). Metas Mundiales de Nutrici\u00f3n 2025: Documento Normativo Sobre Bajo Peso al Nacer. Available online: https:\/\/www.who.int\/es\/publications\/i\/item\/WHO-NMH-NHD-14.5."},{"key":"ref_8","unstructured":"(2025, May 23). Nacimientos por Edad de la Madre y Peso del Nacido. Available online: https:\/\/www.ine.es\/jaxiT3\/Tabla.htm?t=31941&L=0."},{"key":"ref_9","unstructured":"Gowen, C.W. (2023). Nelson. Pediatr\u00eda Esencial, Editorial Elsevier. [9th ed.]."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cpt.166","article-title":"Neonatal drug therapy: The first frontier of therapeutics for children","volume":"98","author":"Allegaert","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental Pharmacology\u2014Drug Disposition, Action, and Therapy in Infants and Children","volume":"349","author":"Kearns","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000360648","article-title":"Clinical Pharmacology in Neonates: Small Size, Huge Variability","volume":"105","author":"Allegaert","year":"2014","journal-title":"Neonatology"},{"key":"ref_13","unstructured":"Kliegman, R.M., Blum, N.J., Shah, S.S., Geme, J.W.S., Tasker, R.C., Wilson, K.M., and Behrman, R.E. (2020). Principios de la farmacoterapia. Nelson. Tratado de Pediatr\u00eda, Elsevier. [21st ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/pm-22-11","article-title":"Pharmacokinetics of drugs: Newborn perspective","volume":"7","author":"Bansal","year":"2024","journal-title":"Pediatr. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"212608","DOI":"10.7573\/dic.212608","article-title":"Neonatal pharmacology and clinical implications","volume":"8","author":"Ruggiero","year":"2019","journal-title":"Drugs Context"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jan.12813","article-title":"Is the ventrogluteal site suitable for intramuscular injections in children under the age of three","volume":"72","author":"Ceylan","year":"2016","journal-title":"J. Adv. Nurs."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1034\/j.1399-6576.1999.430813.x","article-title":"Plasma paracetamol concentrations and pharmacokinetics following rectal administration in neonates and young infants","volume":"43","author":"Hansen","year":"1999","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40262-015-0313-z","article-title":"Challenges Associated with Route of Administration in Neonatal Drug Delivery","volume":"55","author":"Linakis","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4103\/ija.IJA_487_19","article-title":"Pharmacology related to paediatric anaesthesia","volume":"63","author":"Maheshwari","year":"2019","journal-title":"Indian J. Anaesth."},{"key":"ref_20","unstructured":"Fl\u00f3rez, J. (2014). Influencia de los factores gen\u00e9ticos y ambientales, la edad y el embarazo sobre la respuesta a los f\u00e1rmacos. Farmacolog\u00eda Humana, Elsevier. [6th ed.]."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.2174\/1381612811209023119","article-title":"Pharmacokinetics of Drugs in Neonates: Pattern Recognition Beyond Compound Specific Observations","volume":"18","author":"Smits","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003088-199018010-00002","article-title":"Plasma Protein Binding of Drugs in Pregnancy and in Neonates","volume":"18","author":"Notarianni","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"ref_23","first-page":"170","article-title":"Neonatal Pharmacology: Extensive Interindividual Variability Despite Limited Size","volume":"16","author":"Tayman","year":"2011","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40495-016-0078-6","article-title":"Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-Drug Interactions in Adult Life","volume":"3","author":"Piekos","year":"2017","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/FTD.0b013e31806db3f5","article-title":"Renal Drug Clearance in Preterm Neonates: Relation to Prenatal Growth","volume":"29","author":"Allegaert","year":"2007","journal-title":"Ther. Drug Monit."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/apa.15557","article-title":"How should we assess renal function in neonates and infants?","volume":"110","author":"Filler","year":"2021","journal-title":"Acta Paediatr."},{"key":"ref_27","unstructured":"(2025, May 23). Evaluaci\u00f3n de la Funci\u00f3n Renal en el Reci\u00e9n Nacido. Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Available online: https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/03_renal.pdf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1203\/01.pdr.0000245909.74166.00","article-title":"Effect of Diet on the Development of Drug Metabolism by Cytochrome P-450 Enzymes in Healthy Infants","volume":"60","author":"Blake","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, F., Clapham, D., Krysiak, K., Batchelor, H., Field, P., Caivano, G., Pertile, M., Nunn, A., and Tuleu, C. (2019). Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112688"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120296","DOI":"10.1016\/j.ijpharm.2021.120296","article-title":"Neonatal and pediatric oral drug delivery: Hopes and hurdles","volume":"597","author":"Mfoafo","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_31","unstructured":"Valverde Molina, E. (2011). Farmacia Pedi\u00e1trica Hospitalaria, Elsevier Doyma. [1st ed.]."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/archdischild-2013-304887","article-title":"Intravenous drug delivery in neonates: Lessons learnt","volume":"99","author":"Sherwin","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.pone.0204427","article-title":"Use of off-label and unlicensed medicines in neonatal intensive care","volume":"13","author":"Costa","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Perez, M., D\u00e9caudin, B., Maiguy-Foinard, A., Barth\u00e9l\u00e9my, C., Lebuffe, G., Storme, L., and Odou, P. (2017). Dynamic Image Analysis To Evaluate Subvisible Particles During Continuous Drug Infusion in a Neonatal Intensive Care Unit. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10073-y"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.2009.174268","article-title":"Compatibility of drug infusions in the NICU","volume":"95","author":"Kalikstad","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"ref_36","unstructured":"(2025, May 23). Guideline on Pharmaceutical Development of Medicines for Paediatric Use. Available online: https:\/\/www.ema.europa.eu\/en\/pharmaceutical-development-medicines-paediatric-use-scientific-guideline."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/archdischild-2014-306798.7","article-title":"Accuray of enteral syringes for liquid medicines prescribed in children","volume":"99","author":"Gurung","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2017.12.042","article-title":"Zinc delivery from non-woven fibres within a therapeutic nipple shield","volume":"537","author":"Maier","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pedn.2018.04.007","article-title":"Parent and Nurse Satisfaction Using Pacidose\u00ae Oral Medication Delivery Device in the Pediatric Emergency Department: A Pilot Study","volume":"42","author":"Hansen","year":"2018","journal-title":"J. Pediatr. Nurs."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijpharm.2012.05.035","article-title":"A nipple shield delivery system for oral drug delivery to breastfeeding infants: Microbicide delivery to inactivate HIV","volume":"434","author":"Gerrard","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_41","unstructured":"(2025, May 23). Dr. Brown\u2019sTM PacidoseTM Liquid Medicine Dispenser with Oral Syringe. Available online: https:\/\/www.drbrownsbaby.com\/product\/pacidose-liquid-medicine-dispenser\/?highlight=pacidose."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2021167","DOI":"10.1590\/1984-0462\/2023\/41\/2021167","article-title":"Compounded medications for cardiovascular use in neonatology: An integrative review","volume":"41","author":"Greenhalgh","year":"2022","journal-title":"Rev. Paul. Pediatr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1080\/14767058.2016.1238897","article-title":"Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants","volume":"30","author":"Demir","year":"2017","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.2174\/1381612823666170918122136","article-title":"Aerosol: A Novel Vehicle for Pharmacotherapy in Neonates","volume":"23","author":"MacLoughlin","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1089\/jamp.2012.0996","article-title":"A Novel Continuous Powder Aerosolizer (CPA) for Inhalative Administration of Highly Concentrated Recombinant Surfactant Protein-C (rSP-C) Surfactant to Preterm Neonates","volume":"26","author":"Pohlmann","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40290-018-0243-9","article-title":"Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered","volume":"32","author":"Valeur","year":"2018","journal-title":"Pharm. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2013.11.014","article-title":"Effective use of transdermal drug delivery in children","volume":"73","author":"Guy","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"(1987). Simplified Calculation of Body-Surface Area. N. Engl. J. Med., 317, 1090\u20131098.","DOI":"10.1056\/NEJM198710223171717"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpam.2020.09.003","article-title":"Estimation of body surface area in neonates, infants, and children using body weight alone","volume":"8","author":"Lindemalm","year":"2021","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"key":"ref_50","unstructured":"(2025, May 23). Reglamento (CE) n\u00b0 1901\/2006 del Parlamento Europeo y del Consejo, de 12 de Diciembre de 2006, Sobre Medicamentos para uso Pedi\u00e1trico y por el que se Modifican el Reglamento (CEE) n\u00b0 1768\/92, la Directiva 2001\/20\/CE, la Directiva 2001\/83\/CE y el Reglamento (CE) n\u00b0 726\/2004. Available online: https:\/\/www.boe.es\/buscar\/doc.php?id=DOUE-L-2006-82668."},{"key":"ref_51","unstructured":"(2025, May 23). The Situation of Pediatric Medicinese in the UE at Ten Years of the Pediatric Regulation, COM\/2017\/0626 (2017). Available online: https:\/\/eur-lex.europa.eu\/legal-content\/ES\/TXT\/?uri=CELEX%3A52017DC0626."},{"key":"ref_52","unstructured":"(2025, May 23). Real Decreto 175\/2001, de 23 de Febrero, por el que se Aprueban las Normas de Correcta Elaboraci\u00f3n y Control de Calidad de F\u00f3rmulas Magistrales y Preparados Oficinales, Pub. L. No. Real Decreto 175\/2001, BOE-A-2001-5185 9746 (2001). Available online: https:\/\/www.boe.es\/eli\/es\/rd\/2001\/02\/23\/175."},{"key":"ref_53","unstructured":"(2025, May 23). Formulario Nacional. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Available online: https:\/\/www.aemps.gob.es\/formulario-nacional\/."},{"key":"ref_54","unstructured":"(2025, May 23). BOE-A-2006-13554 Ley 29\/2006, de 26 de Julio, de Garant\u00edas y Uso Racional de los Medicamentos y Productos Sanitarios. Available online: https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2006-13554."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101138","DOI":"10.1016\/j.siny.2020.101138","article-title":"The hypertensive neonate","volume":"25","author":"Flynn","year":"2020","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_56","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (2025, May 23). Hipertensi\u00f3n Arterial. Protocolos Diagn\u00f3stico-Terap\u00e9uticos de la AEP. Available online: https:\/\/www.aeped.es\/sites\/default\/files\/documentos\/12_hta.pdf."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3476(88)80292-0","article-title":"Treatment of neonatal hypertension with captopril","volume":"113","author":"Mirkin","year":"1988","journal-title":"J. Pediatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-3476(88)83213-X","article-title":"Renal failure in sick hypertensive premature infants receiving captopril therapy","volume":"112","author":"Tack","year":"1988","journal-title":"J. Pediatr."},{"key":"ref_59","unstructured":"(2025, May 23). Formulario Nacional. FN\/2018\/FMT\/024 Captopril 1 mg\/mL Soluci\u00f3n Oral. Available online: https:\/\/www.aemps.gob.es\/formulario-nacional\/monografias\/formulas-magistrales-tipificadas-pediatricas\/fn_2018_fmt_024.pdf."},{"key":"ref_60","unstructured":"(2025, May 23). CIMA: Centro de Informaci\u00f3n de Medicamentos. Available online: https:\/\/cima.aemps.es\/cima\/publico\/home.html#."},{"key":"ref_61","unstructured":"Lorenzo, P., Moreno, A., Leza, C., Lizasoain, I., Moro, M.A., and Portol\u00e9s, A. (2018). Vel\u00e1zquez. Farmacolog\u00eda B\u00e1sica y Cl\u00ednica, Editorial M\u00e9dica Panamericana. [19th ed.]."},{"key":"ref_62","unstructured":"(2025, May 23). European Medicines Agency. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/aqumeldi-epar-product-information_en.pdf."},{"key":"ref_63","unstructured":"(2025, May 23). Formulario Nacional. FN\/2021\/FMT\/036 Enalapril Maleato 1 mg\/mL Soluci\u00f3n Oral. Available online: https:\/\/www.aemps.gob.es\/formulario-nacional\/monografias\/formulas-magistrales-tipificadas-pediatricas\/fn_2021_fmt_036.pdf."},{"key":"ref_64","first-page":"104","article-title":"Does the corticosteroid\u2019s treatment during the pre and postnatal period affect the neurodevelopmental outcome of premature newborns?","volume":"37","author":"Uberos","year":"2016","journal-title":"Biomedica"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000515950","article-title":"Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia","volume":"118","author":"Doyle","year":"2021","journal-title":"Neonatology"},{"key":"ref_66","unstructured":"(2025, May 23). European Medicines Agency. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/neofordex-epar-product-information_en.pdf."},{"key":"ref_67","unstructured":"(2025, May 23). Formulario Nacional. FN\/2020\/FMT\/030 Dexametasona 1 mg\/mL Soluci\u00f3n Oral. Available online: https:\/\/www.aemps.gob.es\/formulario-nacional\/monografias\/formulas-magistrales-tipificadas-pediatricas\/fn_2020_fmt_030.pdf."},{"key":"ref_68","unstructured":"(2025, May 23). European Medicines Agency. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/efmody-epar-product-information_en.pdf."},{"key":"ref_69","unstructured":"(2025, May 23). Formulario Nacional. FN\/2024\/FMT\/040 Hidrocortisona 1 mg\/mL Suspensi\u00f3n Oral. Available online: https:\/\/www.aemps.gob.es\/formulario-nacional\/monografias\/formulas-magistrales-tipificadas-pediatricas\/fn_2024_fmt_040.pdf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ADM.0000000000001065","article-title":"Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions","volume":"17","author":"DeLisle","year":"2023","journal-title":"J. Addict. Med."},{"key":"ref_71","unstructured":"(2025, May 23). Formulario Nacional. FN\/2024\/FMT\/041 Gabapentina 50 mg\/mL Soluci\u00f3n Oral. Available online: https:\/\/www.aemps.gob.es\/formulario-nacional\/monografias\/formulas-magistrales-tipificadas-pediatricas\/fn_2024_fmt_041.pdf."},{"key":"ref_72","first-page":"371","article-title":"Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit","volume":"41","year":"2017","journal-title":"Farm. Hosp."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.316.7128.343","article-title":"Unlicensed and off label drug use in paediatric wards: Prospective study","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.curtheres.2019.02.001","article-title":"Global Pediatric Drug Development","volume":"90","author":"Thomsen","year":"2019","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jphp.12580","article-title":"Safe implementation of standard concentration infusions in paediatric intensive care","volume":"69","author":"Stanley","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_76","first-page":"155","article-title":"Implementation of standard concentration medication infusions for preterm infants","volume":"8","author":"Tait","year":"2012","journal-title":"Infant"},{"key":"ref_77","unstructured":"(2025, May 23). Sentinel Event Alert 39: Preventing Pediatric Medication Errors|The Joint Commission. Available online: https:\/\/www.jointcommission.org\/resources\/sentinel-event\/sentinel-event-alert-newsletters\/sentinel-event-alert-issue-39-preventing-pediatric-medication-errors\/."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pds.5354","article-title":"Off-label drug use in neonates and infants in Spain: A five-year observational study","volume":"31","author":"Kargodorian","year":"2022","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/963\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:03Z","timestamp":1760033763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":78,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["pharmaceutics17080963"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17080963","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}